COMMUNIQUÉS West-GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
05/05/2026
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Supernus Announces First Quarter 2026 Financial Results
05/05/2026
Total revenues were $207.7 million in the first quarter 2026, a 39% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $149.1 million in the first quarter [...]
HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule
05/05/2026
DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
05/05/2026
– Alignment with the FDA on the Phase 3 trial design of VCN-01 (zabilugene almadenorepvec) for treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) – – Additional data from VIRAGE Phase 2b clinical trial of [...]
Ligand to Participate in May Investor Conferences
05/05/2026
JUPITER, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. [...]
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
05/05/2026
LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately [...]
The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail
05/05/2026
TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- A momentous abortion issue is suddenly before the U.S. Supreme Court. Two makers of mifepristone, the drug that induces a chemical abortion, immediately petitioned the U.S [...]
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
05/05/2026
Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) -- Gpr124 represents a promising novel target for improving the integrity and function of the blood-retina barrier (BRB) with the goal of slowing, halting, preventing or [...]
SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040
05/05/2026
RANCHO CORDOVA, Californie, 05 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour la validation officielle de ses objectifs de réduction des émissions de gaz à effet de serre (GAS) par la Science Based Targets [...]
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026
05/05/2026
Lyon (France), le 5 mai 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers du premier semestre le mercredi 13 mai [...]
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
05/05/2026
Lyon (France), May 05, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first quarter 2026 financial results on Wednesday, May 13, 2026. The [...]
IBA – TRANSPARENCY NOTIFICATION
05/05/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, May 5th, 2026 – 6 p.m. Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026
05/05/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound [...]
VALNEVA: Declaration of shares and voting rights - Status as of April 30, 2026 taking into account interim information as at May 5, 2026
05/05/2026
VALNEVA Declaration of shares and voting rights Status as of April 30, 2026 taking into account interim information as at May 5, 2026 [...]
IBA – ACQUISITION OF OWN SHARES
05/05/2026
Louvain-la-Neuve, Belgium, May 5 th , 2026 – 6:30 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026
05/05/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026 [...]
IBA – ACQUISITION D’ACTIONS PROPRES
05/05/2026
Louvain-la-Neuve, Belgique, 5 mai 2026 – 18h30 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
IBA SA – NOTIFICATION TRANSPARENCE
05/05/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 5 mai 2026 – 18h Résumé de la notification IBA (Ion Beam Applications SA), le [...]

Pages